Clinical Trial Update: Evaluating the Safety and Efficacy of Ondansetron in the Prevention of Post Endoscopic Retrograde Cholangiopancreatography Pancreatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating ondansetron for preventing post-endoscopic retrograde cholangiopancreatography pancreatitis; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatitis
• Post-endoscopic Retrograde Cholangiopancreatography Pancreatitis

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Tanta University | Conditions: Pancreatic Diseases | Phase 3 | Status: RECRUITING